Send us a text

John Bencich is Chief Executive Officer, at Achieve Life Sciences ( https://ir.achievelifesciences.com/ ), a specialty pharmaceutical company committed to addressing the global smoking and nicotine addiction epidemic through the development and commercialization of the drug compound Cytisinicline. Mr. Bencich is an experienced financial executive who has spent over 20 years guiding financial and corporate strategy in the life sciences and technology industries. Before his appointment to Chief Executive Officer in 2020, he served as Achieve Life Sciences Chief Financial and Operating Officer. Prior to joining Achieve Life Sciences in 2017, Mr. Bencich served as CFO of OncoGenex Pharmaceuticals, a publicly traded biotechnology company. Before joining OncoGenex in 2014, he served as CFO of Integrated Diagnostics and Allozyne, both private VC-backed companies. Earlier he served as the CFO and Treasurer of Trubion Pharmaceuticals, a publicly traded biotechnology company where he helped complete the successful sale of the company to Emergent BioSolutions. Prior to his role at Trubion, he led the global financial operations for Onyx Software Corporation, a publicly traded software company through its sale to Battery Ventures. Mr. Bencich started his career at Ernst & Young LLP. He graduated from the University of San Diego with a BA in Accounting, earned his MBA from Seattle University and was a Certified Public Accountant in the state of Washington for 17 years. 

Support the show